Surveillance of vaccine-related adverse events in the first year of life: A Manitoba cohort study

Journal of Clinical Epidemiology

Volumn 49, Issue 1, 1996, Pages 51-58

  Roberts, Janice D ^a   Roos, Leslie L ^a,d   Poffenroth, Linda A ^a   Hassard, Thomas H ^a   Bebchuk, Judith D ^b   Carter, Anne O ^c   Law, Barbara ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CMAJ   (Canada)

^d ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Adverse events; Immunologic monitoring; Population surveillance; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; POLIOMYELITIS VACCINE;

ADOLESCENT; ARTICLE; CANADA; CHILD HEALTH; DATA ANALYSIS; DATA BASE; DRUG SAFETY; FEBRILE CONVULSION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS MENINGITIS;

EID: 0029988434     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00522-6     Document Type: Article

References (25)

1. Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the Task Force on Pertussis and Pertussis Immunization 1988. Pediatrics 1988; 81(Suppl): 938-984.
2. Howson CP, Fineberg HV. Adverse events following pertussis and rubella vaccines: summary of a report of the Institute of Medicine. JAMA 1992; 267: 392-396.
3. Varughese PV, Carter AO, Acres SE, Furesz J. Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies. Can J Public Health 1989; 80: 363-368.
4. Nkowane BM, Wassilak SG, Orenstein WA, Bart JK, Schonberger LB, Hinman AR, Kew OM. Vaccine-associated paralytic poliomyelitis: United States: 1973 through 1984. JAMA 1987; 257: 1335-1340.
5. Sutter RW, Onorato IM, Patriarca PA. Current poliomyelitis immunization policy in the United States. Pediatr Ann 1990; 19: 702-706.
6. Gale JL, Thapa PB, Wassilak SGF, Bobo JK, Mendelman PM, Foy HM. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine: A population-based case control study. JAMA 1994; 271: 37-41.
7. Rabinovich R, Robbins A. Pertussis vaccines: A progress report. JAMA 1994; 271: 68-69.
8. Adverse events temporally associated with immunizing agents - 1987 report. Can Dis Wkly Rep 1989; 15: 151-158.
9. Scheifele D, Gold R, Duclos P, and members of the Canadian Pediatric Society's Immunization Monitoring Program Active (IMPACT). An innovative hospital-based network for active surveillance of vaccine-associated adverse events, vaccine failures and selected infections in children. In: Proceedings of the 33rd Interscience Conference of Antimicrobial Agents and Chemotherapy [Abstract 1649]. New Orleans, October: 1993.
10. Orenstein WA, Bernier RH. Surveillance in the Control of Vaccine-Preventable Diseases. In: W Halperin, EL Baker Jr. Eds. Public Health Surveillance. New York: Van Nostrand Reinhold; 1992: 76-101.
11. Roos NP, Henteleff PD, Roos LL. A new audit procedure applied to an old question: Is the frequency of T & A justified? Med Care 1977; 15: 1-18.
12. Roos LL, Nicol JP, Johnson CF, Roos NP. Using administrative data banks for research and evaluation: A case study. Eval Q 1979; 3: 236-255.
13. Roos LL, Roos NP, Cageorge SM, Nicol JP. How good are the data? Reliability of one health care data bank. Med Care 1982; 20: 266-276.
14. Roos LL, Mustard CA, Nicol JP, McLerran DF, Malenka DJ, Young TK, Cohen MM. Registries and administrative data: Organization and accuracy. Med Care 1993; 31: 201-212.
15. Roberts JD, Poffenroth LA, Roos LL, Bebchuk JD, Carter AO. Monitoring childhood immunizations: A Canadian approach. Am J Public Health 1994; 84: 1666-1668.
16. Hirtz DG, Nelson KB, Ellenberg JH. Seizures following childhood immunizations. J Pediatr 1983; 102: 14-18.
17. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68: 650-660.
18. Pollock TM, Morris J. A 7-year survey of disorders attributed to vaccination in North West Thames Region. Lancet 1983; 1: 753-757.
19. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA 1990; 263: 1641-1645.
20. Griffith AH. Permanent brain damage and pertussis vaccination: Is the end of the saga in sight? Vaccine 1989; 7: 199-210.
21. Golden GS. Pertussis vaccine and injury to the brain. J Pediatr 1990; 116: 854-861.
22. Cherry JD. "Pertussis vaccine encephalopathy": It is time to recognize it as the myth that it is. JAMA 1990; 263: 1679-1680.
23. The International Classification of Diseases, 9th Revision, Clinical Modification, ICD-9-CM. Annotated Volume 1, Diseases Tabular List. Ann Arbor, MI, Commission on Professional and Hospital Activities; 1986.
24. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis, 2nd ed. Englewood Cliffs, NJ: Prentice Hall; 1988.
25. Fine PEM, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 1992; 136: 121-135.